Investigators have discovered novel cellular pathways behind chemotherapy-resistant glioblastoma cells and a potential biomarker, paving the way for new therapeutic targets.
Exposure to light during sleep was associated with obesity, diabetes and high blood pressure in older adults, according to a recent study.
Damage to particular regions of the brain may influence addiction behaviors, providing insight into potential therapeutic targets for substance use disorders.
A new Northwestern Medicine study has identified how ketamine works so quickly, and how it might be adapted without side effects.
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease held the 28th annual Alzheimer Day on May 5, returning to campus for the first time in three years.
Northwestern Medicine scientists have discovered a master gene that programs ear hair cells’ development, overcoming a major hurdle towards restoring hearing.
The Michael J. Fox Foundation for Parkinson’s Research has chosen Northwestern to receive an Edmond J. Safra Fellowship in Movement Disorders to train a movement disorder clinician-investigator.
Exposure to even moderate ambient lighting during nighttime sleep, harms cardiovascular function during sleep and increases your insulin resistance, according to a new study.
Recent advances from Northwestern investigators have powered a new, deeper understanding of Parkinson’s disease that could pave the way to a disease-modifying treatment.